Biotech · Private company
Biofrontera Bioscience GmbH
Track this companyFree. Adds Biofrontera Bioscience GmbH to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- BF-200 ALA and red light LED lampPhase 1 · Actinic KeratosesClinicalTrials.gov · fetched Nov 12, 2026
- BF-200 ALA and red light LED lampPhase 1 · Actinic KeratosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and PhotodamagePHASE1 · COMPLETED · started Jun 27, 2025ClinicalTrials.gov NCT07053852 · fetched Nov 12, 2026
- Cryotherapy in Combination With Red Light PDT for Actinic Keratosis of Full FacePHASE4 · ACTIVE_NOT_RECRUITING · started May 3, 2023ClinicalTrials.gov NCT06745999 · fetched Nov 12, 2026
- Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper ExtremitiesPHASE4 · UNKNOWN · started May 15, 2022ClinicalTrials.gov NCT05359419 · fetched Nov 12, 2026
- Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and ScalpPHASE1 · COMPLETED · started Dec 1, 2021ClinicalTrials.gov NCT05060237 · fetched Nov 12, 2026
- Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)PHASE1 · COMPLETED · started Mar 5, 2020ClinicalTrials.gov NCT04319159 · fetched Nov 12, 2026